A total of five studies assessed the main cellular and molecular effector pathways whereby GLP-1 agonists modulates osteoarthritis [[20], [21], [22],24,25] (Table 2 and Appendix 1 eTable 1). This evidence concerns the gene GCG and osteoarthritis.